A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer's Disease, Dementia with Lewy-Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity

MLA

Bart N.M. van Berckel, et al. “A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer’s Disease, Dementia with Lewy-Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity.” SSRN Electronic Journal, Jan. 2018. EBSCOhost, https://doi.org/10.2139/ssrn.3307650.

APA

Bart N.M. van Berckel, Begoña Indakoetxea, Estrella Morenas-Rodríguez, Cornelis Blauwendraat, Christopher Morris, Patrick F. Chinnery, Iris E. Jansen, Danielle Posthuma, Eliezer Masliah, Ingmar Skoog, Heinz Wiendl, Jordi Clarimón, Adela Orellana, Carmen Lage, Neill R. Graff-Radford, Monica Diez-Fairen, Michael Wagner, Rosa Rademakers, Tanis J. Ferman, … Sonja W. Scholz. (2018). A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer’s Disease, Dementia with Lewy-Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3307650

Chicago

Bart N.M. van Berckel, Begoña Indakoetxea, Estrella Morenas-Rodríguez, Cornelis Blauwendraat, Christopher Morris, Patrick F. Chinnery, Iris E. Jansen, et al. 2018. “A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer’s Disease, Dementia with Lewy-Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity.” SSRN Electronic Journal, January. doi:10.2139/ssrn.3307650.